All In Biotech

Drug Trial Radar · NCT03229200

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.

Last checked: Nov 20, 2026Latest source record: Oct 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

297

Actual

Start

May 22, 2017

Primary completion

May 10, 2027

Study completion May 10, 2027

Sponsor

Lead sponsor
Pharmacyclics Switzerland GmbHAbbVie (ABBV)
Sponsor type
Industry
Collaborators
Janssen Biotech, Inc., including Johnson & Johnson
First posted
Jul 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicenter, open-label, prospective treatment protocol that provides continued access to ibrutinib to subjects who have completed parent ibrutinib studies, are still benefitting from treatment with ibrutinib, and have no access to commercial ibrutinib for their underlying disease within their region.

Conditions

  • Lymphoma, B-Cell
  • Lymphoma, Non-Hodgkin
  • Leukemia, B-cell
  • Graft Vs Host Disease
  • Solid Tumor

Interventions

  • IbrutinibDrug

    Subjects will continue with the current ibrutinib dosing regimen established in the parent ibrutinib study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Characterize the drug safety profile by collecting long-term safety data for ibrutinib.Time frame: Up to 3 years and will be re-evaluated on an ongoing basis.

Locations

98 sites in 17 countries. Site status is shown where the registry gives one.

  • Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center

    Burbank, California

  • City Of Hope National Medical Center

    Duarte, California

  • UCSD Moores Cancer Center

    La Jolla, California

  • University of California Los Angeles (UCLA)

    Los Angeles, California

  • Stanford University

    Stanford, California

  • Emory University

    Atlanta, Georgia

  • Northwestern University

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • Norton Medical Plaza II, 3991 Dutchmans Lane

    Louisville, Kentucky

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • TRIO - Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • John Theurer Cancer Center, Hackensack UMC

    Hackensack, New Jersey

  • San Juan Oncology Associates

    Farmington, New Mexico

  • Northwell Health

    New Hyde Park, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Weill Cornell Medical College-New York Presbyterian Hospital

    New York, New York

  • University of Rochester

    Rochester, New York

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Southeastern Medical Oncology Center

    Goldsboro, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

  • Mid Ohio Oncology/Hematology Inc., DBA The Mark H. Zangmeister Center

    Columbus, Ohio

  • University of Pennsylvania Abramson Cancer Center

    Philadelphia, Pennsylvania

  • Vanderbilt Ingram Cancer Center

    Nashville, Tennessee

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

  • M.D. Anderson Cancer Centre

    Houston, Texas

  • US Oncology Research, LLC

    The Woodlands, Texas

  • University of Vermont Medical Center

    Burlington, Vermont

  • Swedish Cancer Institute

    Seattle, Washington

  • Northwest Cancer Specialists, Compass Oncology

    Vancouver, Washington

  • Wenatchee Valley Hospital and Clinics

    Wenatchee, Washington

  • Yakima Valley Memorial Hospital

    Yakima, Washington

  • St. George Hospital

    Kogarah, New South Wales, Australia

  • Concord Repatriation General Hospital - Haematology Clinical Trials

    Sydney, New South Wales, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

  • Ballarat Health Services

    Ballarat, Victoria, Australia

  • Eastern Health

    Box Hill, Victoria, Australia

Showing 40 of 98 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.